Frees Fund
VC Fund
Beijing, China
Frees Fund is a VC fund in Beijing focused on Artificial Intelligence and Health Care. By adopting revolutionary mechanisms, FREES FUND is devoted to change the long-established rules in the venture capital. By leveraging the cutting-edge technologies and resources, FREES FUND aims at investing in great startups and helping them grow into great enterprises that are valuable to our society. We mainly invest in early-stage startups, and hope to become their first-round institutional investor. Our primary interested areas are broad-sense TMT (Technology, Media, Telecom), B2B and deep technology.
- Total investments:
- 244
- Last investment:
- Lead investor:
- 27%
- Fund size:
- $144M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Frees Fund invests in
Stages Frees Fund invests in
Countries Frees Fund invests in
Round sizes
Contacts
Round size
- Seed
- $1.4M–$14M
- Angel
- $447k–$10M
- Series A
- $1.6M–$28M
Investment Focus
Industry
- Artificial Intelligence 27 (11%)
- Health Care 22 (9%)
- Medical 17 (7%)
- Biotechnology 17 (7%)
- Manufacturing 16 (7%)
Stage
- Series A 73 (30%)
- Angel 55 (23%)
- Seed 50 (20%)
- Series B 25 (10%)
- Series C 6 (2%)
Country
- China 138 (57%)
- United States 17 (7%)
- Singapore 4 (2%)
- Hong Kong 2 (1%)
- Malaysia 1 (0%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Feng Li
Founding Partner
|
Founding Partner | Total investments: 12 | Find email | |
|
Li Feng
Founding partner
|
Founding partner | Total investments: 6 | Find email | |
|
Ma Rui
Partner
|
Partner | Total investments: 5 | Find email | |
|
Shen Ying
Vice President
|
Vice President | Total investments: 4 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
Clarify intelligence
|
Clarify Intelligence is an artificial intelligence technology company focused on the research, development, and deployment of AI-driven software and intelligent solutions. The company specializes in developing foundational AI platforms, application software, and advanced AI algorithms to support a wide range of industry use cases. | Seed / Oct 08, 2026 | |
| Flysound is a hearing technology company focused on making advanced AI-powered hearing aids affordable and accessible. Its products combine AI sound processing, Bluetooth connectivity, app-based personalization, and rechargeable convenience. With a focus on innovation, quality, and user-friendly design, Flysound aims to help people hear moreclearly and stay connected to everyday life. | Angel / Aug 10, 2026 | ||
Yanming Biology
|
Pyrotech pharmaceuticals is a biotechnology company that focuses om development for drugs for the treatment of inflammation and tumors. | Series B / Jul 03, 2026 | |
|
Clarify intelligence
|
Clarify Intelligence is an artificial intelligence technology company focused on the research, development, and deployment of AI-driven software and intelligent solutions. The company specializes in developing foundational AI platforms, application software, and advanced AI algorithms to support a wide range of industry use cases. | Seed / Jun 30, 2026 | |
|
Huiguang Innovation
|
Huiguang Innovation is a provider of robot tactile sensors and tactile data solutions. It mainly provides high-performance visual and tactile sensors, tactile data acquisition equipment and systematic tactile perception solutions for embodied intelligence, robot dexterity operation, intelligent manufacturing, human-computer interaction andscientific research scenarios. | Seed / Jun 24, 2026 | |
|
Analog Devices
|
Analog Devices is a modern analog computing technology company that specializes in the research and development of analog computing, in-memory computing, and AI chip architecture. | Seed / Jun 08, 2026 | |
|
Baiyao Technology
|
Baiyao Technology is a biopharmaceuticals company offering drug and treatment plan development utilizing AI simulation of life processes. | Seed / Jun 05, 2026 | |
|
Wange Intelligence
|
Wange Intelligence operates as an edge infrastructure company focused on the AI/Agent. | Angel / Jun 01, 2026 | |
|
Zhuma Innovation
|
Zhuma Innovation offers 3D reconstruction services of consumer quality. It focuses on consumer-grade 3D reconstruction and spatial intelligence, offering a new class of 3DGS cameras and developing the next generation of spatial imaging terminals, all supported by 3DGS (3D Gaussian Splash) core technology. | Angel / May 25, 2026 | |
|
Natural will
|
Natural will is an intelligent robot developer that focuses on the research, development, manufacturing, sales and technical services of intelligent robots. | Angel / Apr 27, 2026 | |
| See all 244 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Frees Fund invest in?
Frees Fund invests primarily in Artificial Intelligence, Health Care and Medical startups, most often at Series A and Angel stage. Most of the 244 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Frees Fund invest in?
Frees Fund typically joins rounds of $1.4M–$14M at Seed, $447k–$10M at Angel and $1.6M–$28M at Series A. These are whole funding-round sizes, not Frees Fund's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Frees Fund took part in.
How do I contact Frees Fund?
Public channels for Frees Fund include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Frees Fund?
The team at Frees Fund includes Feng Li (Founding Partner), Li Feng (Founding partner) and Ma Rui (Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
